2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA)
Citation:
Pediatric Rheumatology
2008
6(Suppl 1):S1
Volume 6 Supplement 1
Page 1 of 7
2022 Citation Impact
2.5 - 2-year Impact Factor
3.0 - 5-year Impact Factor
1.035 - SNIP (Source Normalized Impact per Paper)
0.732 - SJR (SCImago Journal Rank)
2023 Speed
18 days submission to first editorial decision for all manuscripts (Median)
94 days submission to accept (Median)
2023 Usage
1,095,144 downloads
691 Altmetric mentions